Latest News

Journal Articles

Brain and neurologic

Zika vaccine yields promising results for treating glioblastoma

Has the secret of the immortality cancer switch been unlocked?

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients


ESMO18: New combination therapy for breast cancer may prolong survival

What are the top 5 breast cancer advancements of 2018?

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial


Data-driven blood test could be a step towards personalized treatment for bowel cancer

Chemicals found in vegetables prevent colon cancer in mice

Colorectal cancer screening age to be lowered to 50 in England


Blood test could detect kidney cancer up to 5 years earlier

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

FDA approves first-in-class treatment for rare adrenal tumors


A remarkable insight into the cancer journey of Barbara Moss

Conference Chair highlights: World Congress on Gastrointestinal Cancer

ESMO WCGI: Trifluridine and tipiracil show promise as metastatic gastric cancer treatment in Phase III trial


Could urine liquid biopsies help monitor bladder cancer treatment?

NICE approves atezolizumab for advanced bladder cancer patients on the NHS

Breakthrough method to diagnose prostate cancer developed


ESMO18: Olaparib maintenance improves progression-free survival in advanced ovarian cancer by 3 years

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Targeting BRAF mutations to treat ovarian cancer

Head and neck

Diabetics face a higher risk of mouth cancer, with women more at risk

The importance of a multidisciplinary team in the care of head and neck cancer

The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer


Personalized prediction scheme for myeloproliferative neoplasms developed

NHS England strikes deal for ground-breaking CAR-T therapy in a new European first

NICE rejects Kymriah® for adults with lymphoma


It’s checkmate for Opdivo small-cell lung cancer trial

IASLC 19th WCLC: highlights and the biggest headlines

IMpower133: Atezolizumab extends overall survival for extensive-stage small-cell lung cancer


ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer

ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer


Circulating tumor cells: researchers develop mechanism for characterizing function

Immunotherapy may be an effective therapy for prostate cancer with mismatch repair mutations

Hair loss gene could be exploited to improve cancer immunotherapy

Rare tumors

Osteoblastoma genetic marker shows promise for identifying aggressive tumors

Best of ASCO18: key takeaways & the practice-changing talks

Practice-changing breakthrough made for rare cancer


FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma

NICE approves dabrafenib–trametinib for BRAF+ melanoma

Hair loss gene could be exploited to improve cancer immunotherapy